JC: Azithromycin in patients hospitalised with COVID-19

As we near the end of 2020, it is worth taking a moment to reflect on what a year it has been. At the beginning of the year we were first hearing about a respiratory virus in China. In March 2020 the adaptive platform RECOVERY (randomised evaluation of COVID-19 therapies) trial started recruiting hospitalised patients … Continue reading JC: Azithromycin in patients hospitalised with COVID-19